Venus Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 13-12-2024
- Paid Up Capital ₹ 10.00 M
as on 13-12-2024
- Company Age 31 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.76 M
as on 13-12-2024
- Satisfied Charges ₹ 0.50 M
as on 13-12-2024
- Revenue %
(FY 2021)
- Profit -69.57%
(FY 2021)
- Ebitda 11.60%
(FY 2021)
- Net Worth -0.34%
(FY 2021)
- Total Assets -0.10%
(FY 2021)
About Venus Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 10.00 M.
The company currently has active open charges totaling ₹0.76 M. The company has closed loans amounting to ₹0.50 M, as per Ministry of Corporate Affairs (MCA) records.
George Alexander, George Jacob, Susan Thomas, and One other member serve as directors at the Company.
- CIN/LLPIN
U85195KL1993PLC007306
- Company No.
007306
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Aug 1993
- Date of AGM
29 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- LocationKottayam, Kerala
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Venus Diagnostics?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
George Jacob  | Director | 30-Mar-2015 | Current |
| George Alexander | Director | 30-Mar-2015 | Current |
| Susan Thomas | Director | 30-Mar-2015 | Current |
Georgie Kurien  | Director | 10-Oct-2011 | Current |
Financial Performance of Venus Diagnostics.
Venus Diagnostics Ltd, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 69.57% decrease in profit. The company's net worth dipped by a decrease of 0.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Venus Diagnostics?
In 2020, Venus Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mmg Credit Marketing Services Private LimitedActive 5 years 11 monthsGeorge Jacob is a mutual person
Muthoot Royalex Forex Services Private LimitedActive 8 years 7 monthsGeorge Alexander is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Icici Bank Limited Creation Date: 30 Mar 2005 | ₹0.76 M | Open |
State Bank Of Travancore Creation Date: 11 Apr 2002 | ₹0.50 M | Satisfied |
How Many Employees Work at Venus Diagnostics?
Unlock and access historical data on people associated with Venus Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Venus Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Venus Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
